Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Clearance paves the way for brand-new savings opportunities for cath labs nationwide
News | Cath Lab
Innovative Health Expands into Cath Lab with Clearance to Reprocess Eagle Eye Digital IVUS Catheter

May 31, 2022 —  Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
Built on the market-leading IN.PACT Admiral DCB technology, the IN.PACT 018 DCB is engineered to cross tight lesions and designed for better deliverability
News | Drug-Eluting Balloons
Medtronic Announces FDA Approval for IN.PACT 018 PTA Balloon Catheter

May 27, 2022 — Medtronic today announced approval from the U.S. Food and Drug Administration (FDA) for the IN.PACT 018 ...

Home May 27, 2022
Home
The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained drug release, similar to a drug-eluting stent (DES).
News | Drug-Eluting Balloons
MedAlliance’s SELUTION SLR Drug-eluting Balloon Receives FDA Investigational Device Exemption Approval

May 27, 2022 — The SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a ...

Home May 27, 2022
Home
The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has identified this as a Class I recall, the most serious type of recall.
News | Cath Lab
Abbott Medical Recalls Dragonfly OpStar Imaging Catheter for Potential Loose Catheter Marker Band

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
The ŌNŌ is intended to simplify bailout procedures in the expanding world of structural heart disease interventions
News | Structural Heart
ŌNŌCOR Receives FDA Clearance for Novel Endovascular Retrieval Technology

May 25, 2022 — ŌNŌCOR LLC, a leader in endovascular safety technology, today announced it has received 510(k) U.S. Food ...

Home May 25, 2022
Home
Percutaneous coronary interventions remain below pre-pandemic levels
News | STEMI
Nationwide Study Finds Significant Decline in Treatment for Heart Attacks During Pandemic

May 23, 2022 — New findings from the Ascension Health System’s internal National Cardiovascular Data Registry (NCDR) ...

Home May 23, 2022
Home
Findings underscore need to examine social factors that impact healthcare outcomes for most vulnerable
News | STEMI
New Study Finds Low-income Patients at Higher Risk of Death After Heart Attack

May 20, 2022 — Results from a retrospective analysis reveal significantly higher mortality rates for low-income ...

Home May 20, 2022
Home
First study to compare safety and eficacy of clopidogrel and aspirin monotherapy beyond 12 months in high-risk PCI population
News | Cardiovascular Clinical Studies
Long-term Use of Clopidogrel Monotherapy Associated with Lower Patient Risk Compared to Aspirin Motherapy

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
New Analysis Shows the Evolution of Intervention Techniques in Chronic Total Occlusion Patients
News | Chronic Total Occlusion (CTO)
International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...

Home May 20, 2022
Home
Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.
News | Peripheral Artery Disease (PAD)
New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
Abbott TriClip G4 device
News | Structural Heart
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

May 20, 2022 — Abbott announced two late-breaking data presentations highlighting both TriClip, a first-of-its kind ...

Home May 20, 2022
Home
First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions
News | Peripheral Artery Disease (PAD)
Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.
News | STEMI
International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...

Home May 19, 2022
Home
30-day findings from the DIPRA study demonstrate distal radial artery access poses no increased hand dysfunction risk
News | Radial Access
Novel Distal Radial Access for Cardiac Catheterization Shown as a Safe Strategy Compared to Conventional Radial Access

May 19, 2022 — Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and ...

Home May 19, 2022
Home
Khaldoon Alaswad, M.D., director of catheterization lab at Henry Ford Hospital in Detroit. Image courtesy of Henry Ford Health
News | Chronic Total Occlusion (CTO)
Henry Ford Cardiologist to Perform a Live Heart Procedure at International Medical Education Event

May 18, 2022 — For the third straight year, Henry Ford Hospital interventional cardiologist Khaldoon Alaswad, M.D. will ...

Home May 18, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now